Improving beta-cell secretory function and glycaemia in young-onset type 2 diabetes: A pilot, 12-month, randomized trial of a novel, continuous glucose monitor-guided, rapid treatment intensification strategy incorporating empagliflozin and liraglutide

DIABETES OBESITY & METABOLISM(2022)

引用 0|浏览10
暂无评分
关键词
beta-cell function, CGM, glycaemic control, young-onset type 2 diabetes
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要